Order Article Reprints

Moreno-Pérez D, Korobova A, Croche-Santander FdB, Cordón-Martínez A, Díaz-Morales O, Martínez-Campos L, Pérez-González E, Martínez-Padilla MdC, Santos-Pérez JL, Brioso-Galiana J, et al. Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND). Vaccines. 2025; 13(2):175. https://doi.org/10.3390/vaccines13020175

Moreno-Pérez, David, Aleksandra Korobova, Francisco de Borja Croche-Santander, Ana Cordón-Martínez, Olga Díaz-Morales, Leticia Martínez-Campos, Elena Pérez-González, María del Carmen Martínez-Padilla, Juan Luis Santos-Pérez, Jaime Brioso-Galiana, and et al. 2025. "Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND)" Vaccines 13, no. 2: 175. https://doi.org/10.3390/vaccines13020175

Moreno-Pérez, D., Korobova, A., Croche-Santander, F. d. B., Cordón-Martínez, A., Díaz-Morales, O., Martínez-Campos, L., Pérez-González, E., Martínez-Padilla, M. d. C., Santos-Pérez, J. L., Brioso-Galiana, J., Sánchez-Códez, M. I., Del Diego-Salas, J., Rivera-Izquierdo, M., & Lorusso, N. (2025). Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND). Vaccines, 13(2), 175. https://doi.org/10.3390/vaccines13020175